about
PGC-1α, a potential therapeutic target for early intervention in Parkinson's diseaseParkinson's Disease and Its Management: Part 1: Disease Entity, Risk Factors, Pathophysiology, Clinical Presentation, and DiagnosisOrganochlorine pesticide levels and risk of Parkinson's disease in north Indian populationMeeting report: consensus statement-Parkinson's disease and the environment: collaborative on health and the environment and Parkinson's Action Network (CHE PAN) conference 26-28 June 2007β-Hexachlorocyclohexane levels in serum and risk of Parkinson's diseaseGenetic variability of histamine receptors in patients with Parkinson's disease.Parkinsonism in patients with a history of amphetamine exposure.Caffeine protects against combined paraquat and maneb-induced dopaminergic neuron degenerationA study on risk factors for Parkinson׳s disease in Indian population.Gene expression profiling combined with bioinformatics analysis identify biomarkers for Parkinson disease.Integrative analyses of proteomics and RNA transcriptomics implicate mitochondrial processes, protein folding pathways and GWAS loci in Parkinson diseaseIdentifying the genetic components underlying the pathophysiology of movement disorders.Misfolded α-synuclein and Toll-like receptors: therapeutic targets for Parkinson's disease.Oxidative stress in genetic mouse models of Parkinson's disease.Genetic basis of Parkinson's disease: inheritance, penetrance, and expression.Calcium signaling in neurodegenerationNeuronal Glutathione Content and Antioxidant Capacity can be Normalized In Situ by N-acetyl Cysteine Concentrations Attained in Human Cerebrospinal Fluid.Expression and replication of virus-like circular DNA in human cells.
P2860
Q24597726-8DC77E74-8A77-40B8-852F-898D32F281E3Q28384572-D3A1DFA5-CB07-44B9-9A11-2837A70BBEB6Q28386428-EA04FF23-2F69-45F4-ADB1-74996DCB3585Q28387116-60F81FDA-5A12-44E9-B22D-52BA5F843995Q28392112-573CF0AD-B6DC-4ECE-9FC6-AE44D1C5D1D1Q33325644-399D52B3-F423-47EE-9D45-6E7F72DAB3AFQ33698983-5C44A895-C315-4FC2-81A1-31052694F126Q33828847-8811F3D6-EF83-4A78-80FC-D2814375A9A6Q33947699-EE8E32EF-67E8-4712-BFE5-9B23A5869BF0Q34533646-3EBDDF98-051D-4BC6-807D-2F44B5F410C1Q35899904-733B5BF5-8974-49E5-9797-F043DC0AFE10Q36925207-1F08A59E-6E57-4B10-9258-EC491EE54DC6Q37968039-A1EE3C1D-F542-4748-BBBC-D0B8B9B9115BQ38029327-229D9855-DC13-4EC8-8052-EADC12484614Q38115298-0F5FAB55-14E8-48B5-AEBC-46E28B005FFBQ42199396-236EF423-6D49-4D5E-968C-A395D5E8D14EQ42870393-9FB7F8AC-2195-4AD2-BA50-6D78F7FA9818Q49243600-EAA89234-F5C3-4AE1-8933-D6603601C5A4
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Nongenetic causes of Parkinson's disease.
@ast
Nongenetic causes of Parkinson's disease.
@en
type
label
Nongenetic causes of Parkinson's disease.
@ast
Nongenetic causes of Parkinson's disease.
@en
prefLabel
Nongenetic causes of Parkinson's disease.
@ast
Nongenetic causes of Parkinson's disease.
@en
P2093
P1476
Nongenetic causes of Parkinson's disease
@en
P2093
P304
P356
10.1007/978-3-211-45295-0_23
P577
2006-01-01T00:00:00Z